Skip to main content

Table 1 Baseline characteristics of participants

From: Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial

  Intervention - CGM Control - POCM
(n = 87) (n = 90)
Age (years) 664 (14.0) 67.2 (11.4)
Women 45 (52%) 35 (39%)
BMI (kg/m2) 27.8 (7.0) 27.4 (5.8)
Weight (kg) 81.8 (21.7) 83.2 (21.5)
History of diabetes* 18 (21%) 21 (23%)
History of renal failure** 10 (12%) 5 (6%)
Reason for ICU admission   
Surgical   
 Elective 19 (22%) 16 (18%)
 Emergency 12 (14%) 13 (14%)
Medical 56 (64%) 61 (68%)
Admission diagnosis   
Post cardiac surgery 12 (14%) 11 (12%)
Severe sepsis/septic shock 23 (26%) 18 (20%)
Pneumonia 12 (14%) 11 (12%)
Cardiac failure 10 (12%) 9 (10%)
COPD 3 (3%) 8 (9%)
Hemorrhagic shock 7 (8%) 10 (11%)
Cardiac arrest/resuscitation 10 (12%) 14(16%)
Other 10 (12%) 9 (10%)
APACHE IV predicted mortality (%) 32 (10-70) 31 (20-60)
SOFA score on admission 8 (6-10) 7 (6-10)
Blood glucose level on admission (mmol/L) 9.0 (2.6) 9.2 (2.5)
Mechanical ventilation 80 (92%) 83 (92%)
  1. Data are mean (SD), median (IQR) or n (%). *Diabetes was defined as present when this diagnosis was mentioned in the medical history; **renal failure was present when the preadmission serum creatinine was above 177umol/l. CGM: continuous glucose monitoring, POCM: point-of-care monitoring, BMI: body mass index, ICU: intensive care unit, SOFA: sequential organ failure assessment, COPD: chronic obstructive pulmonary disease; APACHE: acute physiology and chronic health evaluation.